Three news post that show up on the homepage.
The NIH has awarded WashU Medicine an $11.7 million grant to study how inflammation drives myeloproliferative neoplasms, a group of blood cancers at high risk of progressing to acute myeloid leukemia. “This funding supports a true team-science effort because all four projects look at inflammation, but each in a different way,” said principal investigator Stephen T. […]
In this study, WashU Researchers discovered how protein homeostasis mechanism, unfolded protein response (UPR) signaling regulates blood cell lineage output. Given that UPR signaling is upregulated in many cancers, this study provides important insights into targeting UPR signaling as therapeutic strategies. Their findings were published in Blood Advances. Choi, H., Jung, S.-E., Earth, Y., Paik, H., […]
This study by WashU Researchers shows that a novel blood-based digital PCR test can detect when treatment is failing a median of three months before standard of care testing identifies treatment failure —enough lead time to change therapy and potentially improve outcomes for these patients. Findings of this study have been published in Haematologica. Noor, A., […]